IPA by design
Experience leads the way into a new era of accessible solutions.
From experience comes knowledge. No other CRO can offer the depth, breadth and experience that comes with greater than 3,000 completed monoclonal programs, over 35 years. From knowledge comes the wisdom to know how to hone massive amounts of intelligence into meaningful information for biotherapeutic research.
Join us at the next event
Date: Dec 13-16 | 2023
Location: San Diego, USA
Lead the way with IPA.
We have the longest memory
Rabbit monoclonal antibodies with B Cell Select® with Function-First from IPA are unmatched for early identification of a high affinity, highly specific antibodies.
Bispecifics & IPA
Bring us your scaffold and we can do the rest. With years of experience using a variety of bi- and multi-specific modalities, IPA has end-to-end capabilities and throughput to ensure selection and development of the most relevant therapeutic candidates.
Wet lab + in silico
LENSai in silico applications for radically informed decisions are designed to lend great cost and time efficiencies, as part of the IPA antibody discovery portfolio of service.
1. ROOTS 2022: Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035; p.118